摘要
目的:评价更昔洛韦治疗流行性腮腺炎患儿的疗效。方法:选择流行性腮腺炎患儿180例,将其随机分为观察组和对照组。两组患儿常规辅助治疗相同,同时对照组加用利巴韦林;观察组使用更昔洛韦。结果:观察组的总有效率为97.78%(88/90),高于对照组的总有效率88.89%(80/90),两者比较,差异有统计学意义(P<0.05);两组患儿在治疗过程中均未见明显不良反应。结论:更昔洛韦治疗流行性腮腺炎疗效佳,并有良好的安全性,可建议临床进一步推广应用。
Objective：To evaluate the efficacy of ganciclovir in treatment of children with mumps. Methods：180 cases of mumps patients were randomly divided into observation group and control group. The two groups were given conventional adjuvant therapy.While the control group were treated with ribavirin,the observation group were treated with ganciclovir. Results：The total effective rate of the observation group was 97.78%（88/90） ,the control group was 88.89%（80/90） ,the two groups had significant difference（P0.05）;the two groups had no apparent adverse reactions. Conclusion：The ganciclovir in treatment of mumps has efficacy and good security,it is worth further studying.
出处
《中国当代医药》
2010年第19期71-72,共2页
China Modern Medicine
